Why is trough sampling timing critical for vancomycin and aminoglycosides?

• A. Timing does not affect interpretation.
• B. Incorrect timing can misrepresent exposure; vancomycin troughs are drawn just before the next dose; aminoglycosides require peak and trough for efficacy and toxicity risk assessment.
• C. Only peak timing matters.
• D. Only random sampling is recommended.

Answer: (C)

The main idea is that when you measure drug levels, the timing relative to the dose determines what the concentration tells you about exposure in the dosing interval. A trough sample, taken just before the next dose, captures the minimum concentration between doses and reflects how quickly the drug is cleared. This minimum level is what you use to judge whether the patient stays within the target exposure over time, which is crucial for drugs with narrow safety margins.

For vancomycin, trough levels are used as a practical surrogate for overall exposure (the relationship to AUC is why clinicians monitor them). Drawing the trough just before the next dose gives a reliable picture of the lowest level the patient experiences, guiding dose adjustments to maintain efficacy (enough exposure) while avoiding toxicity. If the timing is off, the trough won’t accurately represent exposure, and you may underdose or risk nephrotoxicity.

For aminoglycosides, the situation is a bit different: peak concentrations are tied to bactericidal activity, but trough concentrations are closely linked to toxicity risk. In practice, both peak and trough measurements are used to balance efficacy and safety. Even so, the trough timing remains critical because it informs how low the drug goes between doses and helps prevent accumulation that could lead to toxicity.

Saying that only peak timing matters isn’t complete. While peak is important for efficacy with aminoglycosides, trough timing provides essential information about exposure and safety for both drug classes, and improper trough timing can lead to misinterpretation and inappropriate dosing.